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When an  antigen  is injected into a  higher  animal,  a  sequence of reactions 
occurs which culminate in the manifestations of immunity,  e.g., antibody for- 
mation. A number of experimental approaches are available for obtaining in- 
formation on this sequence of reactions.  Specificity studies on the process of 
tolerance induction,  on the  one  hand,  and  on secondary stimulation on the 
other,  carried out by using  pairs of well-defined  cross-reacting  antigens  have 
revealed phenomena which are probably connected with the early phase of the 
immune response.  Tolerance  to  an  antigen  could be overcome by injecting 
antigens which cross-reacted with the "tolerogen"  (1-9); several workers have 
demonstrated  that  an  antigen  may  stimulate  the  production  of  antibodies 
directed to another though related antigen with which the organism had pre- 
viously been in contact (10-15). Both the overcoming of tolerance and the phe- 
nomenon of "original antigenic sin" (16) have been explained  (5, 9, 14) by postu- 
lating certain receptors for antigen whose specificity did not necessarily seem 
to be identical with  the specificity of the antibodies produced. Experimental 
tolerance would be induced on the level of these receptors rather than on the 
level of antibody production.  On  the  basis of these  ideas,  the  finding  of a 
broader specificity of tolerance  than  of the antibodies produced (1,  4,  5,  17) 
could equally well be explained as the existence  of cross-tolerance of serologi- 
cally non-cross-reacting  antigens (18). 
Our  studies were undertaken  to  define,  in  a  suitable  antigen  system,  the 
specificities  of both  tolerance  induction  and  the  induction  of  the  secondary 
response.  The system of lactic dehydrogenase (LDH) isoenzymes appears es- 
pecially promising  for such specificity studies (for review see Kaplan, reference 
19). It consists  of five tetrameric enzyme proteins which are composed of two 
types of subunits, A and B, in all possible combinations. Subunit A and B (in 
their tetrameric form) do not cross-react serologically (20, 21, 22). The following 
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LDH antigens were chosen for our studies: LDH-I, subunit composition BBBB; 
LDH-III,  subunit composition BBAA; LDH-V,  subunit composition AAAA.  1 
The  characteristic features of  this  antigen  system  are  obvious: It  allows for 
arranging two sets of antigenic determinants either on the same or on two sep- 
arate  molecules.  It does not  require  the  use  of carrier molecules,  nor  should 
combining  both  types  of  determinants  change  their  serological  properties. 
The results of our studies show that subunit A  plays a  predominant role in 
the  process  of  tolerance  induction  to  LDH-III  and  in  the  stimulation  of  a 
secondary response  to  the  enzyme,  whereas  the  antibody population induced 
by LDH-III  consists  of  approximately equal amounts  of  anti-A and  anti-B 
antibodies. 
Materials and Methods 
Enzymes.-- 
LDH-I:  Crystalline LDH  from  pig  heart  was  prepared  essentially as  described  by 
Wachsmuth and Pfleiderer  (23). Since the enzyme is stable in  2 u  ammonium  sulphate at 
75°C, the protein fraction precipitated from the crude extract by ammonium  sulphate (70% 
saturation) was subjected to these conditions  for 5 rain. The mixture was then centrifuged, 
and the enzyme was crystallized from the supematant by addition of ammonium  sulphate. 
It was then pmified further by ammonium  sulphate fractionation up to a specific activity of 
18,000-22,000 Bticher units. The yield was 3-6 g from 14 kg heart tissue. From this prepa- 
ration, LDH-I was isolated by passage through a column of DEAE-Sephadex AS0 (Pharmacia, 
Uppsala, Sweden) equilibrated with 0.01 M phosphate buffer, pH 7.2, containing 0.2 zt NaCI. 
Under these conditions,  LDH-H, -HI, -IV, and -V were  not  adsorbed  to the exchanger, 
whereas LDH-I passed the column very slowly. LDH-I was crystallized from the eluate by 
addition of solid ammonium  sulphate and recrystaUized once from 0.067 ~ phosphate buffer. 
The yield was 1.5-2 g of 3 g LDH applied to the column. In most cases, the enzyme was rechro- 
matographed in the same way. All enzyme preparations used had specific activities  of 20,000- 
24,000 Bticher  units and were electrophoreticaily  homogeneous  (contamination with hybrid 
LDH enzymes <0.1 ~o). In passive hemagglutination inhibition tests, the enzyme was shown 
to contain 0.1~oo or less of A subunits after a single chromatography. 
LDH-V: LDH from porcine  skeletal muscle was prepared as described by J~esai  (24) or 
obtained from Boehringer and Soelme GmbH., Mannheim,  Germany. The preparations had 
specific activities of 30,(}(X}-40,000 Biicher units. They contained LDH-V very predominantly. 
To eliminate the cont,~nlnating hybrid enzymes, each enzyme preparation was passed through 
a  column of DEAE-Sephadex A50 equilibrated with 0.01 ~  phosphate buffer, pH 7.2  (25). 
Under these conditions, LDH-V passes the column, whereas all hybrid enzymes are adsorbed 
to the exchanger.  Since, in the case of LDH-V, a very high degree of purity is required (see 
Results),  the enzyme preparations were chromatographed  twice. They then had specific ac- 
tivities of 35,000-40,000 Biicher units and were homogeneous in electrophoresis  (a contami- 
nation of 1 9~0 being detectable). By passive hemagglutination inhibition, the enzyme was 
shown to contain less than 5 X  10  -s w/w contamination of B-specific material. 
Porcine LDH-III was obtained from Boehringer.  This enzyme had been prepared by in 
vitro hybridization of LDH-I and LDH-V according to the conditions described by Markert 
(26). The enzyme was crystalline, the specific activity being 28,000 Biicher units. By analysis 
t LDH-I and LDH-V are occasionally referred to as "pure forms,'* as opposed to the hybrid 
enzyme LDH-IIL FIG.  1.  Titration of antisera to LDH-I  (a) and LDH-V  (b) with the homologous enzyme 
antigens. Agarose electrophoresis and subsequent LDH-specffic staining. The arrows indicate 
the typical position of the free enzyme after electrophoresis. In both cases,  free enzyme is de- 
tected from the second  sample on (first  sample on top).  The smear of  enzymaticaliy active 
material from the reservoir towards the anode is thought to be due to soluble antigen antibody 
complexes present in the reaction mixtures. 
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in agar electrophoresis,  the preparation was shown to contain approximately 1% of LDH-II 
and LDH-IV each, and <0.1% of the pure forms. 
Antibody  Titration.-- The sera of immunized animals were titrated in the following way 
(27):  To  constant amounts of antiserum (0.025 ml) increasing amounts of enzyme antigen 
were added, and the volume of the reaction mixture was adjusted to 0.125 ml with saline (for 
low enzyme concentrations  0. I ml of serum was taken, the final volume again being 0.125 ml). 
Mter mixing and incubating for 1 hr at 37°C and 1 hr at room temperature, the samples were 
subjected to agarose electrophoresis with subsequent LDH-specific staining. Fig. 1 shows the 
typical patterns obtained with LDH-I and LDH-V and homologous antisera. The equivalence 
point of a serum was associated with an enzyme concentration which just permits the detection 
of a trace of free enzyme in the supernatant. It was shown by quantitative precipitation that, 
at  this enzyme concentration, maximal precipitation occurs in homologous LDH-anti-LDH 
systems. In heterologous systems, however, the cross-reacting antibodies often precipitate the 
antigen poorly though combining with it. In such a situation, the titration method gives more 
relevant results than quantitative precipitation: In a more or less broad dose range, soluble 
antigen antibody complexes, but no free enzyme, appear in the supernatant upon electropho- 
resis. The titration method as described has the following advantages: (a) it is done rapidly and 
is very reproducible. (b) It is absolutely specific for the enzyme  antigen used. It proved especially 
useful  in that it made possible the titration of an antiserum, in one and the same series of 
reaction mixtures with  both LDH-I  and  LDH-V,  because of the  different electrophoretic 
mobilities of these enzymes. (c) It gives a useful approximation of the antibody content of an 
antiserum. (d) It is sensitive enough for many purposes. Equivalence points of 0.1 /~g per ml 
serum for LDH-I and 1.0 #g per ml serum for I,  DH-V can be determined. In this dose range, 
however, only a very approximate estimation of the equivalence point can be made because 
of the limited sensitivity of the LDH-specific stain. Figs.  2 and 7 show how precisely equiv- 
alence points can be determined by routine titration in the various dose ranges. If necessary, 
a precision approximately two times higher can be achieved. 
Passive Hemagglutination.--Coupling  of LDH-III  to pigeon red  cells  was performed as 
described by Kabat and Mayer (28) with the following modifications: The incubation mixture 
contained 1 ml of LDH-III (2 mg/ml in saline),  1 ml of bovine serum albumin (BSA)  (2 rag/ 
ml in saline), 0.3 ml of washed and packed pigeon red cells, 3.5 ml of 0.15 ~  phosphate buffer 
pH 7.2, 5.1 ml saline, and 0.5 ml bis diazotized benzidine. The use of pigeon red cells instead 
of the commonly used sheep red cells resulted in a somewhat higher sensitivity of the test and 
a  markedly better reproducibility from one red cell batch to the other. Also, because of the 
rapid sedimentation of the pigeon red cells, the test could be read after a very short incuba- 
tion time (15 rain). Bovine serum albumin (Behring Werke, Marburg/Lahn, Germany) was 
used to prevent lysis of the red cells. Bis diazotized benzidine was prepared (28),  stored at 
--70°C, and diluted 1:10 immediately before use. 
The sensitized red cells were washed twice and resuspended in saline.  The passive hemag- 
glutination test was carried out conventionally, except that  10%  normal rabbit serum was 
used for antiserum dilutions. The microtiter equipment we used was obtained from Cooke 
Engineering Co., Alexandria, Va. Results were recorded as +, :t=, and -. 
Passive Hemagglutination Inhibition.--This  was performed by diluting the antiserum in 
10% normal rabbit serum containing various concentrations of inhibitor. Sensitized red blood 
cells were added 15-30  rnin later. Tests were always run in duplicate. The figures  show the 
decrease of hemagglutination titer (expressed  as per cent of the reciprocal highest serum di- 
lution giving a  positive test without inhibitor; logarithmic scale)  plotted vs.  the inhibitor 
concentration (referred to as concentration per ml  of the antiserum dilutions; linear scale). 
As theoretically expected, straight lines were generally obtained over a wide dose range in a 
double logarithmic plot for the homologous system (i.e.,  inhibition by LDH-III of the ag- 
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not true for the heterologous  inhibitors (LDH-I and LDH-V). A double logarithmic plot was 
therefore not chosen. 
Separation  of Hea~y and  Light  Antibodies  by  Sucrose Gradient Centrifugatien.--A  linear 
sucrose gradient (29) ranging from 10%-37% w]v sucrose was prepared in phosphate buffered 
saline, pH  7.2. 0.01-0.5  ml  antiserum and  0.03  ml  of  a  solution  of  beef  liver catalase 
(Boehringer) in saline (2 mg/ml) were layered on the top of the gradient. The total volume was 
5.3 ml. Centrifngation  was done at 0°C in a Spinco model L ultracentri/uge for 16 hr at 35,000 
rpm. using an SW 39 swinging bucket rotor. The gradient was then divided into 12-24 frac- 
tions, and antibody activity was determined by passive hemaggiutination as described above. 
The position of the catalase was checked  in the microplates used for hemagglutination by 
addition of 0.025 ml of 1% H~O2. Since the enzyme has a sedimentation constant of ll.15s 
(30), it is situated in the gradient between the peaks of 19s and 7s antibodies, 
The other biochemical and immunochemical  methods used (determination of protein, LDH 
activity test, LDH-specific staining, agarose  electrophoresis,  double diffusion,  quantitative 
precipitation, specific purification of anti-LDH antibody, acetylation of LDH-I) have been 
described (27). 
Animals.--W'fld type rabbits, supplied by a local breeder, were used throughout. 
Standard Immunization.--The animals were primed by injecting the antigen together with 
Freund's complete adjuvant (Dffco Laboratories Detroit, Mich.). To this end the stock sus- 
pension of the respective LDH-antigen was diluted with 0.15 x~ NaC1 to a concentration of 2 
mg/ml and cleared by centrifugation. The resulting solution contained considerable amounts 
of ammonium sulphate (0.15-0.8 x~), since LDH is kept as a suspension in 0.067 M phosphate 
buffer containing 2 ,~ ammonium sulphate. Since ammonium sulphate stabilizes the enzyme 
and also prevents hybridizntion of LDH-I and LDH-V, the solution was not dialyzed but was 
directly emulsified with an equal part of Frennd's complete adjuvant. Great care was taken to 
assure a homogeneous emulsification.  1.5 ml  of  the  emulsion was then equally distributed 
among the four footpads of the right hind leg. After an interval of 3.5-4 wk, the animals were 
boosted by intravenous injection of 1.5 nag of antigen without adjuvant. In the course of the 
work, it was found that an espedally regular secondary response was obtained by giving two 
intravenous injections, the first consisting of 1.0 nag of antigen, the second 2 days later of 1.5 
rag. Peak antibody titers were reached  7 days after the first injection. 
Induction  o/ Tolerance.--To  induce tolerance, rabbits were  injected with antigen intra- 
peritoneally within the first 24 hr of life. Control animals received  saline containing 0.02 M 
ammonium sulphate. Each single litter consisted of experimental animals and controls. Most 
experimentswere done twice, completely independently  of each other (see Results). Great care 
was taken to acertain the homogeneity of the enzyme preparations used. Though each stock 
preparation had already been subjected to rigid criteria for purity (see above), the foUowing 
precautions were taken in addition. After dialysis against 0.15 xr NaC1 buffered with 0.067 M 
phosphate buffer, pH 7.2, the specific catalytic activity was determined. The dialyzed enzyme 
was stored at most for 48 hr at 4°C. There is no loss of activity during that time. Immediately 
before injection, the solution was centrifuged for 10 rain at 5000 rpm. The animals were then 
injected, and the rest of the enzyme solution was analyzed by dectrophoresis with subsequent 
LDH-spedfic staining for the presence of any contamination with other LDH isoenzymes. 
Such a contamination was in no case detected. 
Statistic,  al Analysis.--The statistical evaluation of the data was based on rank correlation 
of the titers observed in individual animals. The U test of Mann and Whitney as described by 
Lienert (31) was used. The null hypothesis was rejected if P  <0.05. 
RESULTS 
The Standard Immunizatlon.--Like  certain serum proteins, LDH  isoenzymes 
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priming injection of LDH incorporated in complete Freund's adjuvant, how- 
ever, the animals acquire the capacity to respond to an intravenous injection 
of the antigen with a rapid increase of the titer of circulating antibody, typical 
of a secondary response. 
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Fro. 2.  Standard immuni~tion with LDH-III. The response of a representative rabbit is 
shown.  O--O,  anti-I  titers;  D--f:],  anti-V fiters.  Upper and lower limits indicate definite 
excess of antigen and of antibody respectively. Absence of an upper limit means that at the 
given equivalence point just a trace of free enzyme appeared in the supematant. 
The time course d  such an immunization with LDH-III is given in Fig. 2. 
As can be seen from the diagram, the animal in question produced, in comparable 
amounts, antibodies reacting with LDH-I and LDH-V. The immune response 
shown in Fig. 2 is very regular and reproducible. In nearly all animals, consid- 
erable amounts of antibody are formed at the height of the secondary response. 
And no rabbit has been found which formed predominantly anti-I or anti-V 
antibodies on immunization with LDH-III; the ratio of anti-I to aati-V anti- 
bodies is kept rather constant. The relevant data are contained in Fig. 3 (for the 
correlation of anti-I and anti-V  titers in individual animals see  Fig.  9).  In 
general, rabbits with high secondary titers also showed a strong primary reac- K.  ]RA~EWSKY, E.  ROTTL~NDER, G.  PELTRE, AND  B.  MULI.ER  587 
tion,  whereas in poor responders both primary and secondary antibody taters 
were low. Furthermore, since the maximum of the primary response is not easily 
found  and  high  antibody  titers  can  be  determined  more precisely than  low 
ones, peak secondary titers were taken as an expression of the reactivity of an 
animal towards LDH-III and were used in this sense for the calculations. The 
primary reaction  was,  however,  always followed in  the  animals.  Fig.  3  also 
contains the data  obtained  upon  immunization  with LDH-I and LDH-V.  It 
appears  that LDH-I, especially,  is  a  rather  irregular  immunogen in  rabbits. 
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]~o. 3. The immune response of rabbits to porcine LDH-III (top), LDH-I (middle), and 
LDH-V (bottom). Animals were classified according to peak secondary titers  (abscissa). 
Dashed lines, anti-I titers; unbroken lines, anti-V titers. The diagram contains data of various 
independent experiments which yielded similar results. 
According to the extent of the response to that enzyme, our animal population 
seems to contain two groups of animals. 
Immunochemical  Characterization of the System.- 
Types of antibody in standard antisera to LDH: Standard antisera to LDH were 
analyzed for the presence of light and heavy antibody molecules by sucrose gradient 
centrifugation. It was found  (Fig.  4)  that antibody activity was mainly associated 
with 7S IgG in its typical position. This activity was not destroyed by 0.2  •  mer- 
captoethanol. A minor peak of mercaptoethanol-sensitive antibody of the 19S type, 
very probably IgM, was also present in most antisera analyzed. In primary antisera, 
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Previous specificity studies in the LDH system (20-22)  have been carried out by 
using secondary antisera and thus depend largely on the specificity of IgG antibodies. 
In these studies, LDH-I and LDH-V were found to be serologically unrelated. Based 
on the analysis of many individual antisera by titration, it can be stated that if there 
exists a  cross-reaction between the two enzymes, it must be  <0.05 %  for secondary 
antisera to LDH-V and <0.03% for secondary antisera to LDH-I. It was important 
to know whether  I9S antibodies to LDH distinguish, as dearly as IgG antibodies, 
between subunits A and B. We have previously shown (27, 32) that subunits A and B 
indeed possess similar surface areas which, however, are not recognized as antigenic 
determinants, at least as far as 7S antibodies are concerned. It was found (unpublished 
observations) that 19S anti-V antibody reacts poorly, if at all, with LDH-I, and vice 
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F•.  4.  Separation by sucrose gradient centrifugation of antibodies present in a pool of 
secondary antisera to LDH-III. The activity of the fractions obtained was tested by passive 
hemagglutination, using erythrocytes coated with LDH-I (dashed lines) or LDH-V (unbroken 
lines). The antibody activity in fractions 5-11 was completely destroyed by treatment with 
0.2 M mercaptoethanol (1 hr at 37°C), whereas the activity of the main peak persisted. 
versa.  A  low degree of cross-reactivity, however, could exist.  This problem is the 
subject of further investigation. 
Precipitation  of antibodies to LDH-III  by LDH-I and  LDH-V:  The  amounts  of 
precipitating antibody in antisera to LDH-III that react with LDH-I, LDH-III, and 
LDH-V were determined by quantitative precipitin analysis. The results obtained for 
four pools of antisera are given in Table I. It is dear from the data that similar amounts 
of protein can be precipitated from the sera by addition of LDH-III and by successive 
reaction of the sera with LDH-I and LDH-V. 
The absence in antisera to LDH-III of antibodies reacting with both LDH-I and -V: 
If LDH-I and -V are compared in double diffusion by antisem to LDH-III, dear-cut 
reactions of nonidentity are obtained (Fig. 5). A similar result was obtained by titrat- 
ing the antisera for anti-I and  anti-V antibody: Our titration  method  permits  an 
antiserum to be tit.rated with LDI-I-I and  -V in two ways: either by running  two 
separate titration series or by adding both enzymes to  the same serum sample(s) 
(see Materials and  Methods).  Four pools of antisera to LDH-III were repeatedly 
titrated in parellel by both ways. In all eases, the same solutions of the diluted enzymes 
were used for both tests. Consistently, identical titers were obtained in these titrations. K.  RAJEWSKY,  E.  ROTTLANDER,  G.  PELTRE,  AND  B.  MULLER  589 
These  experiments  demonstrate  that  the  majority  of  the  antibodies  present  in 
antisera to LDH-III react only with one type of subunit and not with the other. They 
do not exclude, however, the presence in the antisera  of up to  10% of  cross-reacting 
antibodies. Indeed we found that the amount of protein precipitated from an anti-III 
antiserum by one of the pure forms depended to some extent on whether the antiserum 
had been previously absorbed by the other pure form. The differences observed varied 
from 0 -  15 %  of the total protein precipitated. They did not depend on the presence 
or absence of complement. 
Is  this  effect due  to  the  existence  of  antibodies  reacting  with  both  LDH-I  and 
-V? A variety of individual antisera and pools of antisera to LDH-III were absorbed at 
equivalence  by  LDH-I  or  -V  respectively,  and  the  antibodies  were  dissociated 
from the washed precipitates as previously described  (27).  The antibodies were then 
TABLE I 
Quantitative  Precipitation  of Secondary  Antibody to LDtt-III 
Antibody precipitated by 
Antiserum 






2.03  4-  0.032 
1.83  4-  0.06 
1.47  4-  0.06 
1.65  4-  0.06 
mg/ml serum 
2.23  4-4- 0.06 
2.4  4-  0.1 
1.89  4-4- 0.06 
1.71  4-4- 0.07 
mg/ml serum 
4.32  4-  0.13 
4.2O  -4-  0.15 
3.3  4-  0.2 
3.2  4-4- 0.2 
* Precipitations with LDH-I and LDH-III were done using the complete and  noninacti- 
vated  antisera,  whereas  for  precipitation  with  LDH-V  the  antisera  had  previously  been 
adsorbed  at equivalence with LDH-I. 
The calculation of the absolute errors was based on the evaluation of two extreme curves 
which could be fitted to the experimentally determined points. 
titrated with LDH-I and -V. Consistently, small amounts of antibodies reacting with 
the pure form not used for absorption were detected in the preparations,  the equiva- 
lence point being 10-20 times lower than  the one for the "right" enzyme. 
Since the LDH-I and -V preparations used in these tests were virtually free of any 
contamination  with  hybrid  LDH  enzymes  (see Materials  and  Methods),  this  effect 
could only be due to the existence of cross-reacting  antibodies or to coprecipitation of 
antibody  not  depending  on  a  conventional  serological  similarity  of  LDH-I  and 
LDH-V.  The  latter possibility was  suggested  by  the fact  that  LDH-I and  LDH-V 
showed clear-cut reactions of nonidentity when tested with our antibody preparations 
in double diffusion. To clarify the point further,  antibodies were precipitated  from a 
large pool of anti-III  sera  by LDH-V and  purified.  The  preparation  had  a  concen- 
tration of 40 mg of antibody protein per milliliter. The equivalence points for LDH-V 
and  LDH-I  were  determined  as  9500  #g  and  400  #g  respectively.  The  antibodies 
reacting with LDH-I were precipitated by that enzyme and again purified. As shown 
by analysis  in double  diffusion and  by titration,  the resulting antibody  preparation 
consisted  of  nearly  equal amounts  of anti-I  and  anti-V  antibodies.  Again no cross- 590  TOLERANCE  INDUCTION AND  SECONDARY  STIMULATION 
reacting antibodies could be detected. It is assumed,  therefore, that  there exists very 
little, if any, antibody  reacting with both LDH-I and -V in antisera  to LDH-III. 
Is  antibody  to  LDH-III  as  well adapted  to  the  hybrid  enzyme  as  to  the  pure forms? 
Difficulties arise if one tries  to compare,  on the basis  of the  precipitin reaction,  the 
fitting of anti-III antibodies to LDH-III, on the one hand, and LDH-I and -V on the 
other. These difficulties come from the fact that the hybrid molecule can carry on its 
surface,  at  most,  half  as many  determinants  of either pure  form  as  the  pure  forms 
carry  themselves. Thus,  an antibody  to  the B  subunit  induced by LDH-III may fit 
much better to the hybrid enzyme than to LDH-I but could more readily precipitate 
FIG. 5.  Comparison in double diffusion  of LDH-I and LDH-V, using a pool of secondary 
antisera to LDH-III. 
LDH-I because the density of determinants is higher on that molecule. It may suffice 
to say here, therefore, that antibodies provoked by LDH-III revealed strong similar- 
ities between LDH-III, on the one hand,  and  LDH-I and  LDH-V, on  the other,  in 
precipitin tests  (i.e., quantitative precipitin analysis and double diffusion). 
More  satisfying  results  were  obtained  when  passive  hemagglutination  inhibition 
(1)  was used to test the specificity of the antibodies3 The conditions  of  the  test  were 
chosen  to permit,  as much  as possible,  competition  for the antibody  of  the  antigen 
fixed  onto  the  surface  of  erythrocytes  and  antigen  in  solution.  Fig.  6  shows  the 
behavior of anti-A  and  anti-B  antibodies  from  representative  pools  of  antisera  to 
2 We are indebted to Dr. B. Cinader of the University of Toronto  for suggesting the use 
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FIG. 6.  Specificity of antibody in pooled secondary antisera to LDH-III. Pools E and F 
(top) were adsorbed by LDH-V, pools B and F  (bottom) by LDH-I. Open and filled circles 
and squares represent independent experiments. The inhibitor concentration was converted 
to the concentration in the reaction mixture of subunit B and A respectively. The first serum 
dilution in the plates was 1:16. 
LDH-III. It is evident that the majority of the antibodies to the hybrid cannot dis- 
tinguish, under the conditions of the test, between LDH-III and the respective pure 
form. The test also reveals the existence of a small population of anti-III antibodies 
which seem  to be hybrid-specific.  We have shown that these antibodies can neither 592  TOLERANCE  INDUCTION  AND  SECONDARY  STIMULATION 
be inhibited  by a large excess of the respectivepure form (up to 900 #g/ml of the reac- 
tion mixture) nor by a mixture of LDH-I and LDH-V. As demonstrated in a parallel 
paper (33), however, a nearly complete inhibition  is obtained if one uses an inhibitor 
composed  of two porcine  subunits B and  two rabbit subunits A. Since this enzyme 
had  been prepared in  our laboratory from highly  purified  batches of LDH-I and 
LDH-V,  and  since  the preparation  of  porcine  LDH-III used  in  our  experiments 
was homogeneous  in gel diffusion tests, it is unlikely that our result is due to a con- 
tamination of LDH-III with an antigen unrelated to LDH. Hybrid-specific antibodies 
could not be detected by the quantitative precipifin test (see above) nor were they 
found by titration. Since antibodies are known to vary markedly in their capacity to 
agglutinate red blood cells, the size of the hybrid-specific antibody population may well 
be much smaller than  the  10%  suggested  by passive hemagglutination inhibition. 
When individual antisera were tested, they reflected  very closely in most cases the 
pattern shown  in Fig.  6,  regardless  of whether primary or secondary antisera were 
used. Very rarely did the major antibody population of an antiserum seem to be better 
adapted to the hybrid enzyme than to the pure forms. 
The  Specificity  of  Secondary Stiraulation.--Since  by  immunization  with 
LDH-III the determinants of the A and B subunits are offered to the organism 
on the same molecule, it is of interest to ask whether in the terminal (produc- 
tive) phase of the immune response the anti-A and anti-B antibodies are syn- 
thesized by independent production units, possibly different antibody-producing 
cells.  Our  experiments answered  this question  only partially but  revealed an 
entirely unexpected aspect of the secondary response to LDH-III. 
Rabbits were primed by injection  of LDH-III in  Freund's  adjuvant.  4-5 
wk later, they were boosted by successive intravenous injection of LDH-I and 
-V (or vice versa). Fig.  7 shows the experimental design and the two types of 
responses  obtained  in  these  experiments.  Complete  data  are  contained  in 
Table II. 
A  strong booster response was induced in  19 of 20 animals by injection of 
LDH-V. 5 of 20 animals responded to injection of LDH-I with a booster response 
comparable in respect to anti-I titers to those obtained with  the homologous 
antigen (cf. Fig. 3); the majority of the animals responded to that enzyme only 
slightly or not at all. In all cases, the injection of one of the pure types provoked, 
if successful, the formation of antibodies directed exclusively to that pure type. 
From the data of animals responding to both LDH-I and -V, it is obvious that 
the induction  of a  booster response to one of the pure types did not impair a 
subsequent booster response to the other. 
A  series of attempts was made  to provoke regularly a  secondary response 
to LDH-I in rabbits primed with  the hybrid enzyme. A  further  intravenous 
injection of 5 mg of LDH-I had no effect, nor was intramuscular injection of 
4.5  mg  of  LDH-I  incorporated  in  Freund's  complete  adjuvant  successful. 
Simultaneous secondary injection of LDH-I plus LDH-V was found to produce 
regularly a secondary response to LDH-V but not to LDH-I. K.  RAJEWSKY,  E.  ROTTLA.NDER, O.  PELTRE~  AND  B.  M~'LLER  593 
Since the LDH-III preparation used for immunization had been prepared 
in vitro by freezing and  thawing  of LDH-I and LDH-V in a  certain milieu, 
LDH-I was submitted to the same treatment and recrystallized. The resulting 
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time  after priming  with  LDH-I/!  [do¥~ 
FzG. 7. The response  of two representative rabbits (Nos. 5-4 and 8-4) primed with LDH-IH 
to boosting injections of LDH-I and LDH-V. O--O, anti-I fiters; r-l--[], anti-V titers. For 
further explanation see legend to Fig. 2. 
enzyme preparation could not be distinguished from native LDH-I in gel diffu- 
sion tests, and was also not efficient in stimulating animals primed with LDH- 
III (~  responders). 
At the time of secondary injection, the sera of all animals contained anti- 
bodies  reacting  with  LDH-I.  Passive  hemagglutination  experiments  were 
carried out  to test whether the specificity of these antibodies differed in re- 
sponders and nonresponders to LDH-I. The two examples given in Fig. 8 are 594  TOLERANCE  INDUCTION  AND  SECONDARY STIMULATION 
TABLE II 
Re3~onse of Rabbits Primal wlth LDH-III to Secondary Stimulation with LDtt-I and LDtt-V 
Experi-  Antigen bound per ml serum, ~g* 
ment  -No. 
LDH-I  LDH-V  LDH-I  LDH-V  LDH-I  LDH-V 
Before secondary 
injection 
6-3  5  5-10 
6-4  5  10-20 
6-5  5-10  10-20 
6-6  5-10  10-20 
6-7  1-2.5  10 
8-3  20-40  20-40 
8-4  20-40  20-40 
1-35  40-60  20-40 
1-36  10  10-20 
1-37  10-20  20 
1-38  10-20  20-40 
Before secondary 
injection 
6-8  10-20  20 
6-9  10-20  10-20 
7-0  5-10  10-20 
8-1  1  <5 
8-2  40  40--60 
7 days after secondary 
injection of LDH-I 
60  10 
2.5  10-20 
2.5-5  10 
5  10-20 
20-40  5 
300-400  20-40 
500  10-20 
150-200  20-40 
10-20  10-20 
20  20 
60-80  40 
7 days after secondary 
1-39  10  20-40 
1-40  40-60  40 
1-41  20-40  20 
1-42  10-20  20 
injection of LDH-V 
10  800 
5  150 
5-10  300 
1  50-100 
20  800 
10  400-500 
20  1700 
20-40  500 
10-20  1000-1200 
7  days  after  subse- 
quent  injection  of 
LDH-V 
40  100 
2.5  400 
2.5-5  400 
1-5  200-300 
10-20  10-20 
300-400  800 
500  1000-1200 
150  1600-1800 
5  2O0-4O0 
5-10  800 
40--50  800 
7  days  after  subse- 
quent  injection  of 
LDH-I 
5  600--800 
40  50-100 
20  200-300 
2.5-5  20 
40-60  600 
20-40  2O0-4O0 
20-40  1200-1500 
20  400 
600  600-800 
* Concentrations  corresponding  to  definite  excess  of  antibody  (first  number)  and  of 
antigen  (second  number)  are given. Only  one number  appears  if just  a  trace  of antigen 
was detected in the supematant  at that concentration. 
Boosting injections on day 30 and  day 38  after priming. 
§ Boosting injections on day 37  and  day 45  after priming. 
[] Boosting injections on day 32 and day 41 after priming. Rabbits 1-35-1-38  received on 
day 41  again LDH-I  (5 rag)  and  were boosted with LDH-V 7 days later. 
FIO. 8.  Specificity of anti-I antibody in primary sera of animals primed with LDH-IH and 
responding (No. 1-42) or not responding (No. 1-35) to secondary stimulation with LDH-I. Sera 
were adsorbed by LDH-V. Titers less than 3%  (serum 1-36)  or 8% (serum 142)  correspond 
to serum dilutions <  1: 8. For further explanation see legend to Fig, 6. ,oo~  ~-42 
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representative  of  the  results  obtained.  No  significant  difference  was  de- 
tected. 
Specificity of Tolerance  Induction. Induction of Ityporesponsiveness  to LDH- 
Ill  by Injection of LDtt-V.--The following experiments were undertaken to 
study the influence of injection of LDH-I or LDH-V, respectively, into newborn 
rabbits on a  subsequent immunization with the hybrid enzyme. Our interest 
was focused on two main questions. (a) Does injection of one of the pure types 
at birth depress the formation of antibodies to  the  respective moiety of  the 
hybrid molecule only? (b) Is the predominant role of subunit A in the induction 
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FIG. 9.  Hyporesponsiveness to LDH-III induced by injection of LDH-V into the newborn. 
The responses of individual rabbits to LDH-III  are represented in  the diagram by single 
points indicating peak anti-I (ordinate) and anti-V titers (abscissa) after standard immuniza- 
tion. The dashed line is drawn to facilitate orientation to the ratio of the two titers. The dia- 
gram contains data of two independent experiments the results of which were statistically 
indistinguishable. Filled squares, control group; filled circles,  10 Izg; crosses, 100 ~g; open tri- 
angles, 1-2 mg; open circles, 10-40 mg of LDH-V at birth. Anti-I and anti-V titers of the con- 
trol group are significantly higher than those of the 10-40 mg group (P << 0.01) and of the 1-2 
mg group  (P  <  0.05).  Anti-I titers of the 1-2 mg group are significantly higher than those 
of the 10-20 mg group (P <  0.05); the result was less clear for the anti-V titers (0.1  >  P  > 
0.05). K. RAJEWSKY,  E. ROTTLE._NDER,  G. PELTRE,  AND B. MULLER  597 
of the secondary response to LDH-III reflected by a high capacity of LDH-V, 
as compared with LDH-I, to induce tolerance to LDH-III? 
Rabbits were injected on the day of birth with varying doses of LDH-V. At 
the  ageof 12-14 wk, the animals were immunized with LDH-III by the standard 
immunization procedure. The results obtained are contained in Fig. 9 and they 
permit the following conclusions: (a) Complete unresponsiveness could not be 
achieved with any dose of LDH-V injected. (b) Injection of 10 mg and more 
of LDH-V at birth drastically depressed the immune response to LDH-III. 
TABLE III 
The Specif~ity of Hyporesponsiveness  to LDtt-II1 
Group of rabbits 
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* Immunized  according  to  the  standard  procedure,  subsequent  to  immunization  with 
LDH-III. 
Determined by adding increasing amounts of antigen to constant amounts of antiserum 
and testing the supernatants, after standard  incubation, for the presence of antigen. 
§ Equivalence points for the pure forms ranging from 2.5-40 #g. 
Injection of Img  of LDH-V still led, in the majority of the animals, to a de- 
pressed response to  the hybrid enzyme. Even as little as  100  ~g of LDH-V 
given at birth seemed to exert some tolerogenic action, but the number of ex- 
perimental animals is too low to permit  a  definite statement.  (c) Injection of 
LDH-V at birth,  ff effective, depressed  the  complete response to LDH-III, 
i.e., the anti-V and the anti-I titers. In no case has a dissociation of the two 
antibody titers been found. It should be added that a number of precautions 
were taken upon immunization not to miss unexpected reactions of the animals 
injected at birth. Before the priming injection of LDH-III,  the sera of these 
animals were titrated as routine with LDH-I and LDH-V; antibody activity 
could never be detected. It was also shown that animals injected at birth did 
not  develop,  after priming with LDH-III,  any considerable secondary type 598  TOLERANCE  INDUCTION  AND  SECONDARY  STIMULATION 
response. Animals with a depressed secondary response also showed a depressed 
primary reaction. The time course of the secondary reaction did not differ in 
these animals from the one found in the controls. The antibodies present in sera 
of animals showing a depressed response to LDH-III did not seem to differ in 
any respect from the antibodies in  standard  antisera  to the hybrid enzyme. 
Again there was a majority of 7S IgG and a minority of 19S antibody as re- 
vealed by sucrose gradient centrifugation. Again  they were composed of two 
antibody populations, one directed to LDH-I and the other to LDH-V: LDH-I 
to  3- 
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FIo.  10.  Failure of LDH-I  to induce hyporesponsiveness to LDH-III.  Plot as in Fig. 9. 
Two independent, statistically indistinguishable experiments. Squares, control group; circles, 
20-40 mg of LDH-I at birth. P  >  0.4 for anti-I and anti-V titers. 
and LDH-V showed reactions of nonidentity in double diffusion if compared 
by these antisera;  and  on  titration  the  sera  bound  approximately twice  as 
much LDH-III as either of the pure forms. 
Depression of the response to LDH-III as induced by injection of LDH-V 
was not connected with  a depression of the response to an unrelated antigen. 
Table III shows that tolerant and control animals responded strongly to im- 
munization with human gamma globulin (gift of Dr. P. Grabar). 
Failure of LDH-I to Induce Unresponsiveness to LDtt-III or A cetylated LDlt- 
/.--In  contrast  to  LDH-V,  LDH-I  was  found  to  be  incapable  of  inducing 
hyporesponsiveness to LDH-III within the dose range tested. Injection of 20- 
40 mg of LDH-I in the neonatal period did not result in the animals in any K.  RAJEWSKY,  E.  ROTTL~/.NDER, G.  PELTRE,  AND  ]3.  MTJLLER  599 
significant depression of the anti-I and anti-V titers upon immunization with 
LDH-III (Fig. 10). 
We do not know whether LDH-I can exert any tolerogenic action at all. The 
direct test (namely injection of LDH-I into the newborn and subsequent im- 
munization with the same enzyme) has not yet been carried out because of the 
irregular immune response to LDH-I in rabbits. It has been shown, however, 
that injection of 10-20 mg of LDH-I at birth did not affect the immune response 
of the  animals  towards acetylated LDH-I  (Fig.  11).  This enzyme,  a  potent 
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FIG. 11.  Failure of LDH-I to induce hyporesponsiveness to acetylated LDH-I. Equivalence 
points for LDH-I are plotted versus those for acetylated LDH-I. Each point represents the 
response  of an individual rabbit  (cf.  Fig. 9).  Squares,  control  group; circles,  10-20 gm of 
LDH-I at birth. P  >  0.3 for anti-I and anti-acetylated I  fiters. 
treatment but also  the  complete set of antigenic determinants of the native 
enzyme (27). 
There is, therefore, no evidence as yet for any tolerogenic action of LDH-I. 
DISCUSSION 
Characterization of the System.--Immunizafion  of rabbits with porcine LDH- 
III  leads  to  the  production of  anti-A  and  anti-B  antibodies  in  comparable 
amounts. The ratio of anti-A to anti-B antibodies is remarkably constant. Thus, 
combining subunit A and B on one antigenic molecule results in a characteristic 
imprint on the immune response: We have recently found that priming with a 
mixture of LDH-I and LDH-V often leads to a dissociation of the anti-A and 
the  anti-B  fiters.  These  experiments  will  be  presented  in  another  context, 600  TOLERANCE  INDUCTION  AND  SECONDARY  STL~ULATION 
since they have revealed further interesting features of the immune response 
to LDH. 
It would seem, therefore, that the A and B subunits do not dissociate during 
the initiation of the immune response to LDH-III. This is also suggested by 
the  stability  of LDH-III  under  physiological  conditions.  We have kept the 
enzyme at a concentration of 50 ~g/ml in physiological solution containing 40 
mg BSA/ml for 5 days at 37°C without observing any considerable dissociation 
and reassociation of the subunits. In vitro hybridization of LDH subunits re- 
quires a rather drastic treatment of the enzyme(s) (26). Furthermore, ammo- 
nium sulphate, which is known to be a potent inhibitor of in vitro hybridization 
of LDH, was  always present in the  antigen-adjuvant  mixtures  used  for  im- 
munization. 
Fortunately, the combination of A and B subunits did not impose complexi- 
ties  and  irregularities of antigenic structure  on  the  hybrid molecule to  any 
considerable extent. Virtually all precipitating antibody in anti-III sera can be 
precipitated by successive addition to the sera of LDH-I and LDH-V. There 
exists in the sera very little, if any, antibody reacting with both LDH-I and 
LDH-V. The majority of the antibodies present in the sera fit equally or almost 
equally well to one of the pure forms as to the hybrid enzyme, and only small 
amounts of antibodies specific for LDH-III are found. The system thus meets 
the immunochemical requirements of studies on the specificities involved in the 
induction of tolerance and of the secondary response. 
Stimulation of Animals Primed with LDtt-III by the Pure Forms.--In 1959, 
Dubert performed the following experiment (12): Rabbits were primed with a 
chemically modified human serum albumin and,  after an interval of 31 days, 
boosted with  the  native protein.  In  accord with  a  previous observation by 
Dixon and Manrer  (10),  a  booster response was  obtained for both types of 
antibody inherent in the system, those directed to the native protein and others, 
specific for the chemically modified antigen. As Dubert pointed out, however, 
there was  a  slight cross-reaction of the latter antibodies with native human 
serum albumin. 
We did not find a similar phenomenon in our system. Animals primed with 
LDH-III responded to injection of one of the pure types with a typical second- 
ary  response.  However,  the production of anti-A and anti-B  antibodies  can 
obviously be dissociated from one another. Since a secondary response to one 
of the pure types does not impair the subsequent initiation of a secondary re- 
sponse to the other, and since cell proliferation leading to production cells with 
a limited life span is thought to be an essential step in the secondary response 
(34), the simplest explanation for the observed effects is the assumption  that 
the  last  step  of  the  immune  response to LDH-III  involves cells specifically K.  RAJEWSKY,  E.  ROTTL~.NDER, G.  PELTRE,  AND  B.  MULLER  601 
producing anti-A or anti-B antibodies, but not both. However, as will be dis- 
cussed below,  this conclusion is not cogent, even if one assumes that the  1.5 
mg of antigen injected led to an exhaustive stimulation. It should be kept in 
mind that upon stimulation of animals primed with LDH-III, only 5  of 20 
developed the expected high antibody titers after injection of LDH-I, whereas 
19 of 20 responded strongly to injection of LDH-V. In all animals, at the time 
of secondary stimulation, circulating antibodies to  subunits A  (LDH-V)  and 
B (LDH-I)  were  present  in  the  serum,  sometimes  in  considerable  amounts 
(Table II). The deficiency of LDH-I as a boosting agent can hardly be explained 
on the basis of serological specificity. Our immunochemical studies (see above) 
demonstrated a good fit to LDH-I of most of the anti-B antibodies provoked 
by sensitization with LDH-III. There was also no difference between LDH-I 
and LDH-V in this respect.  Furthermore, primary antisera of animals which 
did not respond to secondary stimulation with LDH-I did not differ in specificity 
from primary antisera of responders (Fig. 8). The possibility that, because of a 
somewhat different serological  specificity, LDH-I is a  poor inducer of a  sec- 
ondary response in animals primed with LDH-III  has been further  excluded 
by experiments with a hybrid LDH molecule composed of porcine B and rabbit 
A subunits (33). This enzyme is very similar to porcine LDH-III in respect to 
the  B-specific  and  the  hybrid-specific determinants,  but  does not induce  a 
secondary response in animals primed with the porcine hybrid enzyme. 
It would thus seem that in the majority of cases, A subunits are necessarily 
involved in the process of induction of a secondary response to LDH-III. One 
might assume that priming with LDH-III leads to the development of a trap- 
ping mechanism (14,  15)  ready to accept antigen for secondary stimulation. 
Subunits A would be required in the majority of our animals for a proper func- 
tioning of this trapping mechanism. 
Further work is necessary to elucidate whether the finding of a minority of 
responders to secondary injection of LDH-I has a genetical background. It is 
of interest in this connection to note that standard immunization with LDH-I 
also led to very irregular results (Fig. 3).  Some strains of laboratory animals 
are reportedly incapable of responding to certain antigens because of a geneti- 
cally determined deficiency of  initiating the  immune response  (35-38).  The 
same would presumably be true in our system, since all rabbits are capable of 
forming anti-B antibodies in large amounts upon immunization with LDH-III. 
Specificity of Tolerance Induction.--The main finding of our tolerance studies 
was that a  tolerogenic  injection of LDH-V depresses the complete antibody 
response to the hybrid enzyme, that is, both the anti-A and the anti-B titers; 
LDH-I does not exert a similar tolerogenic action. There are four possible ways 
of interpreting this result: (a) The LDH-V preparations used were contaminated 602  TOLERANCE  INDUCTION  AND  SECONDARY  STIMULATION 
with hybrid enzymes. (b) The immune apparatus of the newborn rabbit cannot 
distinguish between LDH-I and LDH-V, but acquires this capacity during  the 
first 3 months of life. (c) LDH-I and LDH-V, though not cross-reacting sero- 
logically,  show  the  phenomenon  of  cross-tolerance.  (d)  Unresponsiveness to 
LDH-III is induced by blocking an early step of the immune response which 
is mediated by subunits A. 
Contamination of our LDH-V preparations with hybrid enzymes is an un- 
likely cause of these results. If such a contamination existed, it must have been 
below 5  X  10  -5, as shown by passive hemagglutination inhibition.  Since 1 mg 
of our preparation induced unresponsiveness in about 50 % of the animals, one 
would have to assume that less  than 0.05 ~g of the hybrid enzyme exerted a 
strong tolerogenic action, which would be contrary to all previous experience 
(39). 
Cross-tolerance of LDH-I  and LDH-V,  found either at birth  only (possi- 
bility b) or as a general phenomenon (possibility c) in the rabbit, would seem 
unlikely  from the data presented here since hyporesponsiveness to LDH-III 
could be induced by LDH-V, but not by LDH-I, in the dose range tested. The 
two  enzymes seemed  to  differ strongly in  this  respect: Whereas  1 mg,  and 
probably even 100 ug, of LDH-V was sufficient to induce  hyporesponsiveness 
in a proportion of the animals, 40 mg of LDH-I had no effect at all.  It could 
be argued, however, that LDH-I, though unable to induce tolerance, possesses 
a certain tolerogenic specificity, possibly identical with that of LDH-V. Further 
experimental work, which is included in a parallel paper (33), has shown that 
hyporesponsiveness  to  the  hybrid  molecule  can  be  easily  induced  in  adult 
rabbits, again by injection of LDH-V but not of LDH-I. The possibility that 
our results are attributable to delayed development of the ability to distinguish 
between subunits A and B  is therefore excluded. Furthermore, cross-tolerance 
of LDH-I and LDH-V could be shown not  to exist by direct testing.  Thus 
there remains possibility (d), namely, the existence of a  step requiring A sub- 
units in the early phase of the immune response to LDH-III; this step could 
be blocked by a tolerogenic injection of LDH-V. 
It is striking that the experiments on secondary stimulation and on tolerance 
induction independently lead to similar conclusions. Indeed, our data reveal a 
similarity of the processes of tolerance induction and of initiation of the im- 
mune response to LDH-III as to their specificity. This similarity is compatible 
with the view that  the two processes are mediated by receptors which upon 
contact  with  antigen  could  either  establish  tolerance  (probably the  normal 
event in the case of LDH) or, in the presence of adjuvant, be transformed or 
multiplied in such a way that a further encounter of the organism with antigen 
leads to antibody formation. The specificity of the receptors in question cannot 
be defined from our data. However, we do not have any evidence for a partici- 
pation of subunits B  at that stage of the immune response in the majority of K.  RAJEWSKY~ E.  ROTTLANDER,  G.  PELTRE,  AND  B.  MULLER  603 
our animals,  and the results  can be explained by attributing to the receptors 
involved just A-specificity.  Whether  this A-specificity  is  identical with the 
specificity of certain antibody combining sites is unknown. The results suggest 
only that the receptors  we are  dealing  with probably are not conventional 
circulating  antibody, since LDH-I was unable to stimulate the majority of our 
animals primed with the hybrid enzyme, though anti-B antibody was present 
in the sera at the time of secondary stimulation (see also Rajewsky and Rott- 
liinder  (33)). On  the other hand, it seems quite possible  that the inductive 
phase of the immune response has its own specificity, which may or may not 
overlap  with conventional serological specificity. This possibility has recently 
also been discussed in studies on the inheritance of the immune response (35- 
38). It should  be noted in this connection  that our system clearly shows a 
hapten-carrier effect, and the results may thus have a bearing on carrier effects 
in general. Together with the DNP-polylysine-BSA  system (37), the LDtt sys- 
tem represents  an example of macromolecular  haptens (the haptenic subunits 
B) being fixed to a carrier of similar size (the carrier subunits A). This aspect of 
the work is discussed in detail in a parallel paper (33). It may well be  that 
hapten-carrier effects of the kind described here are a general phenomenon in 
that generally only certain parts of an antigen molecule possess carrier  prop- 
erty and thus determine the specificity of that antigen during the early phase 
of the immune response. This could help  to explain "breakdown" of tolerance 
and differences between tolerance specificity and the specificity of antibody. 
The receptor concept clearly does not allow any conclusion to be drawn from 
our  experiments  on  secondary stimulation with respect  to  a  possible  single 
commitment of the production cells. The question whether,  in animals primed 
with the hybrid enzyme, the production cells produce  either anti-A or anti-B 
antibodies or both has to be answered by direct testing. In a very recent study 
(40, 38) it was shown that in a similar system the antibody producing cells were 
committed to the production of one type of antibody only. 
Finally, it should be pointed out that tolerance  may well be inducible  at 
several stages of the immune response. A very clearcut  example of tolerance 
with respect to single antigenic determinants has been given by Schechter and 
coworkers  (41), and various  degrees  of  determinant specificity  arise  in nu- 
merous cases of  experimentally induced unresponsiveness  (see reference  42). 
Most striking,  however,  is  the  determinant specificity  of natural tolerance. 
The factors that determine whether tolerance  is induced at an early or  (in 
addition?) at a late stage of the immune response are not yet clearly defined. 
SUMMARY 
Upon  immunization with LDH-III  (subunit  composition  AABB)  rabbits 
produce  anti-A  and  anti-B  antibodies  in  comparable  amounts.  These  anti- 
bodies fit equally well to the hybrid enzyme and to LDH-V (AAAA) or LDH-I 504  TOLERANCE  INDUCTION  AND  SECONDARY  STIMULATION 
(BBBB)  respectively,  as  tested  by  passive  hemagglutination  inhibition.  No 
antibodies  reacting with both LDH-I  and LDH-V were detected.  A  minority 
of hybrid-specific antibodies was, however, present in the sera. 
Animals primed with LDH-III respond regularly to a  boosting injection  of 
LDH-V with the production of large amounts of anti-A (but not anti-B)  anti- 
bodies. A  similar injection of LDH-I stimulates  (if it has any effect at all)  the 
production of anti-B  antibodies  only. Stimulation  with one of the pure  types 
does not impair a subsequent response to the other. 
The majority of the  animals primed with LDH-III responded  not at all or 
weakly to a  boosting injection  of LDH-I,  though antibodies  to LDH-I were 
present  in  the  sera  at  the  time  of stimulation.  This  effect can hardly be ex- 
plained on the basis of serological sepcificity. 
Hyporesponsiveness to LDH-III can be induced by injection of LDH-V into 
the newborn.  Both anti-A and anti-B  titers  are equally  depressed.  Within the 
dose range tested, LDH-I does not exert any tolerogenic action with respect to 
LDH-III. 
The  carrier  property  of subunit  A  is  evident  in  the  induction  of both  im- 
munity and tolerance to LDH-III. The early phase of the immune response to 
the hybrid enzyme may be carrier-specific,  and receptors for the haptenic sub- 
unit B  may not exist at that stage. 
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